Sunday, February 3, 2019

GeneQuantum Healthcare and MITRO Biotech Enter into Strategic Cooperation to Develop Next Generation Radionuclide Conjugates

SUZHOU, China, Feb. 3, 2019 /PRNewswire/ -- On February 1, 2019, GeneQuantum Healthcare of Suzhou and MITRO Biotech of Nanjing signed the "Strategic Cooperation Agreement on Next Generation Radionuclide Conjugates Development" in Nanjing. Dr. Gang Qin, President of GeneQuantum and Dr....



from PR Newswire: https://prn.to/2Sm3AI5

No comments:

Post a Comment